4DMEDICAL LIMITED specializes in advanced medical imaging software and hardware tailored for respiratory medicine, using cutting-edge imaging technology to provide detailed insights into lung health. The company is a leader in transforming respiratory diagnostics with its innovative XV Technology, offering non-invasive imaging solutions that significantly improve diagnostic accuracy.
Track bearish sentiment and short interest over time
Historical Price Data
View stock price movements, volume, and trading patterns
Industry & Focus
medical imaging
respiratory healthcare
software and hardware
asx company
innovation
Company Overview
AI-generated company summary
4DMEDICAL LIMITED specializes in advanced medical imaging software and hardware tailored for respiratory medicine, using cutting-edge imaging technology to provide detailed insights into lung health. The company is a leader in transforming respiratory diagnostics with its innovative XV Technology, offering non-invasive imaging solutions that significantly improve diagnostic accuracy.
Company History
Founded in 2012 and headquartered in Melbourne, Australia, 4DMEDICAL LIMITED initially began as a research project focused on developing novel imaging solutions. It progressed to launching its flagship product, utilizing XV Technology, which secured FDA and TGA approvals, marking a major milestone for the company. The company went public on the ASX in August 2020, raising capital to expand its technological capabilities and market reach.
Competitive Advantages
4DMEDICAL LIMITED has proprietary XV Technology that offers non-invasive, detailed lung imaging without the use of contrast agents. The company holds significant market presence due to its FDA and TGA-approved imaging solutions, creating substantial entry barriers for competitors. Strategic partnerships with leading medical centers bolster its research capabilities and market penetration.
Risk Factors
•Regulatory changes could impact product approvals
•High dependency on technological advancements
•Intense competition from established medical imaging companies
Recent Developments
Last 6 months
In the past six months, 4DMEDICAL LIMITED announced an upgrade to its XV Technology to enhance imaging precision. The company reported positive earnings growth in its latest financial report and signed a strategic agreement with a major US hospital to expand its clinical applications.
Key People
Leadership team at 4dmedical
AF
Andreas Fouras
CEO
Andreas Fouras is the founder and CEO of 4DMEDICAL LIMITED, with a background in mechanical engineering and medical technologies. He has been instrumental in steering the company from a startup to becoming a publicly listed entity on the ASX.
TH
Tony Hall
CFO
Tony Hall serves as the CFO of 4DMEDICAL LIMITED, bringing years of experience in financial management and corporate governance, previously holding senior roles in various multinational companies.
Financial Reports
28 reports available
Quarterly Activity Report and Appendix 4C
Quarterly ReportOct 30, 2025via asx_announcements
Annual Report
Annual ReportSep 26, 2025via asx_announcements
FY2025 Full year results
Full Year ResultsAug 29, 2025via asx_announcements
Appendix 4E - Preliminary Final Report
Annual ResultsAug 29, 2025via asx_announcements
Quarterly Activity Report and Appendix 4C
Quarterly ReportJul 31, 2025via asx_announcements
Quarterly Activity Report and Appendix 4C for Q3 FY2025
Quarterly ReportApr 29, 2025via asx_announcements
1H FY2025 Half-year results
Half Year ResultsFeb 28, 2025via asx_announcements
Appendix 4D and Half-Year Report
Half Year ResultsFeb 28, 2025via asx_announcements
Webinar details - 1H FY2025 Half Year Results
Half Year ResultsFeb 27, 2025via asx_announcements
Quarterly Activity Report and Appendix 4C for Q2 FY2025